These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31614000)

  • 1. Potential survival benefit of radiofrequency ablation for small solitary intrahepatic cholangiocarcinoma in nonsurgically managed patients: A population-based analysis.
    Wu L; Tsilimigras DI; Farooq A; Hyer JM; Merath K; Paredes AZ; Mehta R; Sahara K; Shen F; Pawlik TM
    J Surg Oncol; 2019 Dec; 120(8):1358-1364. PubMed ID: 31614000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of liver fibrosis score on prognosis after common therapies for intrahepatic cholangiocarcinoma: a propensity score matching analysis.
    Zhang JX; Li P; Chen Z; Lin H; Cai Z; Liao W; Pan Z
    BMC Cancer; 2020 Jun; 20(1):556. PubMed ID: 32539768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ERCP-directed radiofrequency ablation and photodynamic therapy are associated with comparable survival in the treatment of unresectable cholangiocarcinoma.
    Strand DS; Cosgrove ND; Patrie JT; Cox DG; Bauer TW; Adams RB; Mann JA; Sauer BG; Shami VM; Wang AY
    Gastrointest Endosc; 2014 Nov; 80(5):794-804. PubMed ID: 24836747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment outcomes for unresectable intrahepatic cholangiocarcinoma: Nationwide, population-based, cohort study based on propensity score matching with the Mahalanobis metric.
    Chang WW; Hsiao PK; Qin L; Chang CL; Chow JM; Wu SY
    Radiother Oncol; 2018 Nov; 129(2):284-292. PubMed ID: 30279046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous radiofrequency ablation in intrahepatic cholangiocarcinoma: a retrospective single-center experience.
    Brandi G; Rizzo A; Dall'Olio FG; Felicani C; Ercolani G; Cescon M; Frega G; Tavolari S; Palloni A; De Lorenzo S; Abbati F; Mollica V; Ricci AD; Serra C
    Int J Hyperthermia; 2020; 37(1):479-485. PubMed ID: 32396398
    [No Abstract]   [Full Text] [Related]  

  • 6. Endobiliary radiofrequency ablation for distal extrahepatic cholangiocarcinoma: A clinicopathological study.
    Kim EJ; Chung DH; Kim YJ; Kim YS; Park YH; Kim KK; Cho JH
    PLoS One; 2018; 13(11):e0206694. PubMed ID: 30439965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perioperative blood transfusion does not affect recurrence-free and overall survivals after curative resection for intrahepatic cholangiocarcinoma: a propensity score matching analysis.
    Zhou PY; Tang Z; Liu WR; Tian MX; Jin L; Jiang XF; Wang H; Tao CY; Ding ZB; Peng YF; Qiu SJ; Dai Z; Zhou J; Fan J; Shi YH
    BMC Cancer; 2017 Nov; 17(1):762. PubMed ID: 29137600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of adjuvant treatments for resectable intrahepatic cholangiocarcinoma: Chemotherapy alone, sequential chemoradiotherapy, or concurrent chemoradiotherapy.
    Lin YK; Hsieh MC; Wang WW; Lin YC; Chang WW; Chang CL; Cheng YF; Wu SY
    Radiother Oncol; 2018 Sep; 128(3):575-583. PubMed ID: 29801723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiofrequency Ablation vs. Surgical Resection for Small Early-Stage Primary Intrahepatic Cholangiocarcinoma.
    Xiang X; Hu D; Jin Z; Liu P; Lin H
    Front Oncol; 2020; 10():540662. PubMed ID: 33134161
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of Anatomical Versus Non-anatomical Liver Resection on Short- and Long-Term Outcomes for Patients with Intrahepatic Cholangiocarcinoma.
    Si A; Li J; Yang Z; Xia Y; Yang T; Lei Z; Cheng Z; Pawlik TM; Lau WY; Shen F
    Ann Surg Oncol; 2019 Jun; 26(6):1841-1850. PubMed ID: 30843164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of endoscopic radiofrequency ablation on the survival of patients with inoperable malignant biliary strictures: A large cohort study.
    Xia MX; Wang SP; Yuan JG; Gao DJ; Ye X; Wang TT; Wu J; Zhou DX; Hu B
    J Hepatobiliary Pancreat Sci; 2022 Jun; 29(6):693-702. PubMed ID: 33829657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiofrequency ablation for the treatment of primary intrahepatic cholangiocarcinoma.
    Kim JH; Won HJ; Shin YM; Kim KA; Kim PN
    AJR Am J Roentgenol; 2011 Feb; 196(2):W205-9. PubMed ID: 21257864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of adjuvant therapy after R0 resection for patients with intrahepatic and perihilar cholangiocarcinomas.
    Kim YS; Oh SY; Go SI; Kang JH; Park I; Song HN; Ji JH; Hwang IG; Jang JS
    Cancer Chemother Pharmacol; 2017 Jan; 79(1):99-106. PubMed ID: 27928598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrahepatic Cholangiocarcinoma: Socioeconomic Discrepancies, Contemporary Treatment Approaches and Survival Trends from the National Cancer Database.
    Uhlig J; Sellers CM; Cha C; Khan SA; Lacy J; Stein SM; Kim HS
    Ann Surg Oncol; 2019 Jul; 26(7):1993-2000. PubMed ID: 30693451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Site-specific metastases of intrahepatic cholangiocarcinoma and its impact on survival: a population-based study.
    Yan X; Wang P; Zhu Z; Ning Z; Xu L; Zhuang L; Sheng J; Meng Z
    Future Oncol; 2019 Jun; 15(18):2125-2137. PubMed ID: 31161810
    [No Abstract]   [Full Text] [Related]  

  • 16. Surgical Resection Does Not Improve Survival in Multifocal Intrahepatic Cholangiocarcinoma: A Comparison of Surgical Resection with Intra-Arterial Therapies.
    Wright GP; Perkins S; Jones H; Zureikat AH; Marsh JW; Holtzman MP; Zeh HJ; Bartlett DL; Pingpank JF
    Ann Surg Oncol; 2018 Jan; 25(1):83-90. PubMed ID: 29063296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection.
    Li T; Qin LX; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Tang ZY; Fan J
    Liver Int; 2014 Jul; 34(6):953-60. PubMed ID: 24134199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiofrequency ablation of intrahepatic cholangiocarcinoma: feasability, local tumor control, and long-term outcome.
    Butros SR; Shenoy-Bhangle A; Mueller PR; Arellano RS
    Clin Imaging; 2014; 38(4):490-494. PubMed ID: 24637151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significant Improvement in Outcomes of Patients with Intrahepatic Cholangiocarcinoma after Surgery.
    Yoh T; Hatano E; Nishio T; Seo S; Taura K; Yasuchika K; Okajima H; Kaido T; Uemoto S
    World J Surg; 2016 Sep; 40(9):2229-36. PubMed ID: 27255940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of radiofrequency ablation therapy for patients with unresected Stage IA non-small cell lung cancer.
    Li M; Qin Y; Mei A; Wang C; Fan L
    J Cancer Res Ther; 2020 Sep; 16(5):1007-1013. PubMed ID: 33004741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.